当前位置: 首页 > 详情页

MiR-24 regulates the proliferation and invasion of glioma by ST7L via beta-catenin/Tcf-4 signaling

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Lab Neurooncol,Tianjin Neurol Inst, Tianjin 300060, Peoples R China; [2]Minist Educ & Tianjin Municipal Govt, Key Lab Neurotrauma Variat & Regenerat, Tianjin 300060, Peoples R China; [3]Harbin Med Univ, Dept Neurosurg, Affiliated Hosp 2, Harbin 150086, Peoples R China; [4]Capital Med Univ, Dept Neurosurg, Tiantan Hosp, Beijing 100050, Peoples R China; [5]Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200040, Peoples R China; [6]Harbin Med Univ, Dept Neurosurg, Affiliated Hosp 2, 246 Xuefu Rd, Harbin 150086, Peoples R China
出处:
ISSN:

关键词: miR-24 Glioma ST7L beta-catenin Tcf-4

摘要:
MicroRNAs are strongly implicated as affecting glioma, but their specific roles and functions have yet to be fully elucidated. In this study, we defined the expression and function of miR-24, which we found to be upregulated in glioma samples and glioma cells by qRT-PCR. Downregulation of miR-24 in glioma cell lines inhibited proliferation and invasion and induced apoptosis. Using computational and expression analysis, ST7L was identified as a candidate target of miR-24. A reporter assay with the 3'UTR of ST7L cloned downstream of a luciferase gene showed increased luciferase activity in the absence of miR-24, providing strong evidence that miR-24 is a direct regulator of ST7L. Furthermore, we observed that restoration of ST7L activity resulted in effects that were similar to those from transfecting a miR-24 inhibitor into glioma cells. Mechanistic investigation revealed that the deletion of miR-24 suppressed beta-catenin/Tcf-4 transcription activity by targeting ST7L. In conclusion, our study demonstrates that miR-24 upregulation is common in glioma and that suppression of miR-24 expression inhibits cell proliferation and invasion, suggesting that miR-24 may act as an oncogene in glioma. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 2 区 医学
小类 | 3 区 肿瘤学
最新[2023]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学
JCR分区:
出版当年[2011]版:
Q1 ONCOLOGY
最新[2023]版:
Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2011版] 出版当年五年平均 出版前一年[2010版] 出版后一年[2012版]

第一作者:
第一作者机构: [1]Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Lab Neurooncol,Tianjin Neurol Inst, Tianjin 300060, Peoples R China; [2]Minist Educ & Tianjin Municipal Govt, Key Lab Neurotrauma Variat & Regenerat, Tianjin 300060, Peoples R China; [3]Harbin Med Univ, Dept Neurosurg, Affiliated Hosp 2, Harbin 150086, Peoples R China; [5]Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200040, Peoples R China;
通讯作者:
通讯机构: [3]Harbin Med Univ, Dept Neurosurg, Affiliated Hosp 2, Harbin 150086, Peoples R China; [6]Harbin Med Univ, Dept Neurosurg, Affiliated Hosp 2, 246 Xuefu Rd, Harbin 150086, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院